The Hope App: An Immersive Telehealth Solution for Older Adults With Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes
- Sponsor
- See Yourself Health LLC
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- change in glycemic control
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
This research study will test how a computer program (called the Hope App) teaches diabetes care skills for older adults with diabetes. The study will compare those who receive diabetes education (10 educational modules and monthly health coaching) through the research program with those who receive care as usual.
Detailed Description
The Hope App offers a simple, high-impact, engaging, and immersive telehealth experience with the potential to become a ubiquitous diabetes management tool to transform diabetes patients into high performing drivers of their own care. The research team aims to scale the platform, develop features that are important to aging adults, and run a clinical trial to validate the Hope App's health benefits. * Specific Aim 1: Develop the Hope App's state-of-the-art immersive patient engagement experience with automated onboarding, social networking and gamified DSME/S features to support long-term patient retention. In doing so, usability testing will be performed to ensure patient-facing features on the platform and patient-facing content and curriculum materials are functioning and well received by participants. * Specific Aim 2: Develop the Hope App's predictive analytic capabilities for population health management. * Specific Aim 3: Conduct a clinical validation trial of the Hope App intervention on six-month clinical outcomes (Hemoglobin A1c), patient reported outcomes (diabetes distress) and engagement outcomes (patient retention, adherence to self-care behaviors). The research team intends to deliver a scalable Hope App platform with a usable patient engagement portal designed for older adults and achieve decreases in blood glucose levels (HbA1c) and depressive burden, and sustained patient engagement.
Investigators
Eligibility Criteria
Inclusion Criteria
- •aged 65 years and above
- •diagnosis of type 2 diabetes
- •English-speaking
- •baseline blood sugar value (HbA1c) of 7.5%
- •Internet access
Exclusion Criteria
- •aged less than 65 years
- •non English-speaking
- •unable to provide informed consent
- •diagnosis of type 1 diabetes
- •unable to use a computer or mobile device
- •medical condition for which participation is contraindicated (dialysis, pregnancy, use of insulin pump)
Outcomes
Primary Outcomes
change in glycemic control
Time Frame: baseline and 6 months
change in HbA1c values recorded from point-of-care tests or in the electronic health record at visits. A mean change of 0.5% will be the a priori determined clinically meaningful minimum improvement from baseline to 6 months.
Secondary Outcomes
- changes in self-reported diabetes distress(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- self-reported weight change(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in participant engagement(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in coping skills(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in self-management adherence(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in medication adherence scale(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in depressive burden symptoms(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in general anxiety symptoms(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in perceived support from healthcare providers(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in perceived competence(baseline to 3 months; 3 months to 6 months; baseline to 6 months)
- changes in perceived diabetes self-efficacy(baseline to 3 months; 3 months to 6 months; baseline to 6 months)